Le Lézard
Classified in: Health
Subjects: PDT, SCZ

Blue Cross and Blue Shield of Nebraska and Prime Therapeutics Offer New Medicare Advantage Benefit: OTC Discount Card


OMAHA, Neb., Nov. 25, 2019 /PRNewswire/ -- Blue Cross and Blue Shield of Nebraska (BCBSNE) and their pharmacy benefit manager Prime Therapeutics LLC (Prime) are launching an over-the-counter (OTC) discount card for Medicare Advantage members Jan. 1, 2020.

BCBSNE's Medicare Advantage members will receive a quarterly prepaid card by mail, redeemable for at least $25 per quarter.  The Centers for Medicare & Medicaid Services (CMS) approved card will help purchase nearly 90,000 items like cold and allergy drugs, hearing aid batteries, oral care items and pain relievers. Once the balance has been spent for the quarter, the OTC card converts to a discount card.

"The OTC card benefit helps our Medicare Advantage members save on the supplementary costs of health items and other products that they may not have purchased after filling a prescription," said Tom Gilsdorf, Director of Medicare Advantage at Blue Cross and Blue Shield of Nebraska.  "It can be a difference maker for a person on a fixed income."

As prescription drug costs continue to rise, people struggle to afford medicines. In fact, a recent study showed individuals who pay a large share of the cost for their diabetes medication were less likely to fill their prescription and continue to take it as directed. Yet, taking medication as directed and eating healthy foods has been proven to help stabilize diabetes, leading to fewer complications from the condition.

"It's gratifying for Prime to administer a program that provides members with access to discounted OTC drugs and health products," said Laura Terry, vice president of marketing, communications and product for Prime. "In partnership with BCBSNE, we're making it easier for members to save where and when they like. Ultimately, this program is about improving the overall health of members. And, use of OTC products may help reduce medical expenses like doctor visits, which in turn can drive down overall health care costs."

BCBSNE Medicare Advantage cardholders can scan products using a mobile app or visit an online portal to see participating retailers ? including grocery, pharmacy and convenience stores ? or order products for home delivery. Members can also track their past transactions and card balance.

BCBSNE is one of the first to offer the OTC program. Prime will expand the benefit to additional health plans in 2020.

To learn more about the OTC program visit Nebraskablue.com.

About Prime Therapeutics
Prime Therapeutics LLC (Prime) makes health care work better by helping people get the medicine they need to feel better and live well. Prime provides total drug management solutions for health plans, employers, and government programs including Medicare and Medicaid. The company processes claims and offers clinical services for people with complex medical conditions. Prime serves more than 28 million people. It is collectively owned by 18 Blue Cross and Blue Shield Plans, subsidiaries or affiliates of those plans. For more information visit www.primetherapeutics.com or follow @Prime_PBM on Twitter.

About Blue Cross and Blue Shield of Nebraska
Blue Cross and Blue Shield of Nebraska, Inc. has been serving Nebraskans for 80 years. BCBSNE is part of a mutual health insurance holding company structure committed to providing stability and security to Nebraska families and is leading the way in supporting patient-focused care. BCBSNE is the state's largest health insurance company, and the only one headquartered in Nebraska. Blue Cross and Blue Shield of Nebraska is an independent licensee of the Blue Cross and Blue Shield Association.

Contact:
Marcia Cady
Media Content Strategist
Blue Cross and Blue Shield of Nebraska
402.892.8242
[email protected]

Jenine Anderson
Public Relations Manager
Prime Therapeutics
612.777.5629
[email protected]

 

SOURCE Prime Therapeutics LLC


These press releases may also interest you

at 00:05
ImmunityBio, Inc. , an immunotherapy company, today announced positive overall survival results in the QUILT 3.055 study of 2nd- and 3rd-line NSCLC patients who progressed after checkpoint inhibitor therapy (pembrolizumab, nivolumab, or atezolizumab)...

at 00:05
The Insurance Institute for Highway Safety is updating its vehicle-to-vehicle front crash prevention test to address crashes that occur at higher speeds and those in which the struck vehicle is a motorcycle or large truck. Only one of the first 10...

at 00:00
Nutriessential.com recently announced its expansion into Oceania, Asia, and the Gulf. The company has been providing science-backed GMP-certified supplements in the US, Europe and Canada since 2005 and decided to expand owing to rising global demands...

24 avr 2024
Summit Clinical Research LLC ("Summit") is deeply saddened by the death of Co-Founder and Chairman Dr. Stephen Harrison. Summit mourns Dr. Harrison and extends its heartfelt condolences to his family and loved ones.   During an illustrious 30-year...

24 avr 2024
Shanghai Junshi Biosciences Co., Ltd ("Junshi Biosciences," HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced that the Drug...

24 avr 2024
Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmune, ophthalmology...



News published on and distributed by: